Purpose: The present study aimed to formulate PLGA and PLGA-PEG-galactosamine nanoparticles (NPs) loaded with amphotericin B with appropriate physicochemical properties and antifungal activity. PLGA was functionalized with GalN to increase the adhesion and antifungal activity of NPs against Candida albicans. Methods: The physicochemical properties of NPs were characterized by particle size determination, zeta potential, drug crystallinity, loading efficiency, dissolution studies, differential scanning calorimeter (DSC), X-ray powder diffraction (XRPD), and Fourier transform infrared (FT-IR). Antifungal activity of the NPs at different drug/polymer ratios was examined by determining minimum inhibitory concentrations (MICs). Results: the FT-I...
M.Sc.(Nanoscience)The synthesis and application of gold nanoparticles (AuNPs) has been intensively s...
Cutaneous leishmaniasis (CL) is an infectious, parasitic disease caused by the protozoan Leishmania....
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient populatio...
Purpose: The aim of this work was to formulate sodium alginate nanospheres of amphotericin B by cont...
This paper describes the development of poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs) an...
Xiaolong Tang,1,2,* He Zhu,3,* Ledong Sun,4,* Wei Hou,2 Shuyu Cai,1 Rongbo Zhang,1 Feng Liu5 1Stem C...
Purpose: The aim of this work was to formulate sodium alginate nanospheres of amphotericin B by con...
In recent decades, nanotechnology has made phenomenal strides in the pharmaceutical field, favouring...
Amphotericin B (AMB) is used most commonly in severe systemic life-threatening fungal infections. Th...
AbstractPurposeAmphotericin B (AmB) is an effective anti-fungal and anti-leishmanial agent. However,...
Background and the purpose of the study: Amphotericin B (AmB) which is an appropriate antibiotic for...
Ketoconazole is commonly used in the treatment of topical fungal infections. The therapy requires f...
Amphotericin B (AMB), an effective antifungal and antileishmanial agent associated with low oral bio...
Background: Despite advances in the treatment, the morbidity and mortality rate associated with inva...
P474 Poly Lactic-co-Glycolic Acid (PLGA) uptake by Candida albicans cells as biodegradable controll...
M.Sc.(Nanoscience)The synthesis and application of gold nanoparticles (AuNPs) has been intensively s...
Cutaneous leishmaniasis (CL) is an infectious, parasitic disease caused by the protozoan Leishmania....
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient populatio...
Purpose: The aim of this work was to formulate sodium alginate nanospheres of amphotericin B by cont...
This paper describes the development of poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles (NPs) an...
Xiaolong Tang,1,2,* He Zhu,3,* Ledong Sun,4,* Wei Hou,2 Shuyu Cai,1 Rongbo Zhang,1 Feng Liu5 1Stem C...
Purpose: The aim of this work was to formulate sodium alginate nanospheres of amphotericin B by con...
In recent decades, nanotechnology has made phenomenal strides in the pharmaceutical field, favouring...
Amphotericin B (AMB) is used most commonly in severe systemic life-threatening fungal infections. Th...
AbstractPurposeAmphotericin B (AmB) is an effective anti-fungal and anti-leishmanial agent. However,...
Background and the purpose of the study: Amphotericin B (AmB) which is an appropriate antibiotic for...
Ketoconazole is commonly used in the treatment of topical fungal infections. The therapy requires f...
Amphotericin B (AMB), an effective antifungal and antileishmanial agent associated with low oral bio...
Background: Despite advances in the treatment, the morbidity and mortality rate associated with inva...
P474 Poly Lactic-co-Glycolic Acid (PLGA) uptake by Candida albicans cells as biodegradable controll...
M.Sc.(Nanoscience)The synthesis and application of gold nanoparticles (AuNPs) has been intensively s...
Cutaneous leishmaniasis (CL) is an infectious, parasitic disease caused by the protozoan Leishmania....
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient populatio...